JPS6154016B2 - - Google Patents

Info

Publication number
JPS6154016B2
JPS6154016B2 JP6285179A JP6285179A JPS6154016B2 JP S6154016 B2 JPS6154016 B2 JP S6154016B2 JP 6285179 A JP6285179 A JP 6285179A JP 6285179 A JP6285179 A JP 6285179A JP S6154016 B2 JPS6154016 B2 JP S6154016B2
Authority
JP
Japan
Prior art keywords
acid
melting point
solvent
elemental analysis
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP6285179A
Other languages
Japanese (ja)
Other versions
JPS55154950A (en
Inventor
Kanji Noda
Akira Nakagawa
Toshiharu Motomura
Hiroyuki Ide
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP6285179A priority Critical patent/JPS55154950A/en
Publication of JPS55154950A publication Critical patent/JPS55154950A/en
Publication of JPS6154016B2 publication Critical patent/JPS6154016B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 本発明は一般式() (式中、Xはハロゲン原子を、mは1〜3の整数
を、nは0〜1の整数を意味する)で表わされる
新規なカルボン酸アミド誘導体に関するものであ
る。 本発明者等は先に多くのアントラニル酸誘導体
の合成を行ない、それらの薬理作用を検討したと
ころ顕著な抗炎症作用、抗アレルギー作用等の薬
理作用を有することを見出し特許出願中(特願昭
52―134941(特開昭54―66649号)、特願昭53―
31884(特開昭54―132544号)、特願昭53―149200
(特開昭55―76852号))である。 本発明におけるカルボン酸アミド誘導体は文献
未載の新規化合物であり、しかもアントラニル酸
誘導体を製造する上に重要な中間体である。又そ
れ自身でも抗アレルギー作用、抗炎症作用、鎮痛
作用、鎮静作用等の薬理作用を有し産業上有用な
化合物である。 本発明の化合物は下記の反応式で示す方法によ
つて収率よく得ることが出来るが、これらの製法
は一例にすぎず勿論他の化学的類似方法によつて
も製造することが出来るものである。 製造法 一般式()で表わされる化合物に一般式
()で表わされる安息香酸又はその反応性誘導
体を反応させる方法。 (式中、X、m及びnは前記と同じ意味を有す
る) 前記製造法を更に具体的に説明すると、一般式
()で表わされるアニリン誘導体と一般式
()で表わされる安息香酸誘導体を無溶媒下、
あるいはトルエン、キシレン、エチレングリコー
ル、ジエチレングリコール等の有機溶媒中におい
て加熱脱水反応を行なうか、又は脱水剤(硫酸、
五酸化リン、ポリリン酸、ジシクロヘキシルカル
ボジイミド等)の存在下に室温又は加熱下でエー
テル、ジクロルメタン、ジクロルエタン、ベンゼ
ン、トルエン、キシレン等の有機溶媒中反応を行
なうことにより好収率で目的化合物を得ることが
出来る。又、一般式()で表わされる安息香酸
の反応性誘導体(例えば酸ハライド、酸無水物)
を室温又は加熱下にテトラヒドロフラン、アセト
ン、クロロホルム、ピリジン、ベンゼン、トルエ
ン、キシレン等の有機溶媒中反応させればよい。
又、酸ハライドを使用する場合は脱酸剤(例え
ば、トリメチルアミン、トリエチルアミン、ピリ
ジン、炭酸ナトリウム、炭酸カリウム等)を使用
すれば反応は速やかに進行する。 尚、本発明によつて得られるカルボン酸アミド
誘導体は2〜3倍モルの酸化剤(例えば過マンガ
ン酸カリウム等)の存在下、ピリジン、水、酢酸
等の溶媒中で加熱することにより収率よくアント
ラニル酸誘導体を得ることが出来る。 以下に実施例を示し、本発明を更に具体的に説
明する。 実施例 1 3,4,5―トリメトキシ安息香酸2.1g、乾
燥ベンゼン15ml、塩化チオニル2mlの混合物を3
時間還流したのち減圧下溶媒を留去した。残渣を
乾燥テトラヒドロフラン10mlに溶解し、6―クロ
ル―o―トルイジン1.4gと乾燥テトラヒドロフ
ラン15ml及びトリエチルアミン1.5mlの混合溶液
の中に加え室温にて2時間撹拌した。次に減圧下
で溶媒を留去し、残渣に水を注入して生成物を
取、乾燥後、エタノールより再結晶すると無色プ
リズム晶の3,4,5―トリメトキシベンゾイル
―6―クロル―o―トルイジド3.1gを得た。 この物質の融点、赤外吸収スペクトル、マスス
ペクトル及び元素分析値は次の通りであつた。 融 点 165〜167℃ 赤外吸収スペクトル υc=o(KBr)1630cm
-1 マススペクトル M+335 元素分析値 C17H18CNO4 理 論 値 C:60.81 H:5.40 N:4.17 実 測 値 C:60.74 H:5.47 N:4.23 実施例 2 3,4,5―トリメトキシ安息香酸2.1g、乾
燥ベンゼン15ml、塩化チオニル2mlの混合物を3
時間還流したのち減圧下溶媒を留去した。残渣を
乾燥テトラヒドロフラン10mlに溶解し、4―フル
オロ―o―トルイジン1.3gと乾燥テトラヒドロ
フラン15ml及びトルエチルアミン1.5mlの混合溶
液の中に加え30分間還流した。次にその中に水を
注入して析出する結晶を取、乾燥後、エタノー
ルより再結晶すると無色針状晶の3,4,5―ト
リメトキシベンゾイル―4―フルオロ―o―トル
イジド2.6gを得た。 この物質の融点、赤外吸収スペクトル、マスス
ペクトル及び元素分析値は次の通りであつた。 融 点 173〜175℃ 赤外吸収スペクトル νc=o(KBr)1630cm
-1 マススペクトル M+319 元素分析値 C17H18FNO4 理 論 値 C:63.94 H:5.68 N:4.39 実 測 値 C:63.83 H:5.61 N:4.46 参考例 3,4,5―トリメトキシベンゾイル―5―ク
ロル―o―トルイジド7.0gをピリジン―水の混
合溶液(1:1)中に加え、還流下に過マンガン
酸カリウム9.9gを数回に分けゆつくり加えた。
さらに還流下15時間撹拌した。次に反応物を過
し、液を減圧留去した。残渣に水を加えて不溶
物を過し液を氷冷下に稀塩酸で酸性溶液と
し、析出する結晶を取、乾燥後、アセトンより
再結晶すると無色針状晶のN―(3,4,5―ト
リメトキシベンゾイル)―5―クロルアントラニ
ル酸5.8gを得た。 この物質の融点及び元素分析値は次の通りであ
つた。 融 点 273〜275℃ 元素分析値 C17H16CNO6 理 論 値 C:55.82 H:4.41 N:3.83 実 測 値 C:55.87 H:4.36 N:3.92 実施例 3〜7 実施例1〜2の方法に準じて次に示す化合物を
合成した。 【表】
[Detailed Description of the Invention] The present invention relates to the general formula () (wherein, X represents a halogen atom, m represents an integer of 1 to 3, and n represents an integer of 0 to 1). The present inventors have previously synthesized many anthranilic acid derivatives and studied their pharmacological effects, and found that they have remarkable anti-inflammatory and anti-allergic effects, and are currently applying for a patent.
52-134941 (Unexamined Japanese Patent Publication No. 1983-66649), Patent Application No. 1973-
31884 (Japanese Unexamined Patent Application No. 132544 of 1972), Patent Application No. 149200 of 1977
(Japanese Patent Application Laid-Open No. 55-76852)). The carboxylic acid amide derivative in the present invention is a new compound that has not been described in any literature, and is also an important intermediate for producing anthranilic acid derivatives. It is also an industrially useful compound that has pharmacological effects such as anti-allergic, anti-inflammatory, analgesic, and sedative effects. The compound of the present invention can be obtained in good yield by the method shown in the reaction formula below, but these production methods are only examples, and of course it can also be produced by other chemically similar methods. be. Production method A method in which a compound represented by the general formula () is reacted with benzoic acid represented by the general formula () or a reactive derivative thereof. (wherein, under solvent,
Alternatively, a heating dehydration reaction may be carried out in an organic solvent such as toluene, xylene, ethylene glycol or diethylene glycol, or a dehydrating agent (sulfuric acid,
To obtain the target compound in good yield by carrying out the reaction in an organic solvent such as ether, dichloromethane, dichloroethane, benzene, toluene, xylene, etc., in the presence of phosphorus pentoxide, polyphosphoric acid, dicyclohexylcarbodiimide, etc.) at room temperature or under heating. I can do it. Also, reactive derivatives of benzoic acid represented by the general formula () (e.g. acid halides, acid anhydrides)
may be reacted at room temperature or under heating in an organic solvent such as tetrahydrofuran, acetone, chloroform, pyridine, benzene, toluene, or xylene.
Further, when using an acid halide, the reaction proceeds quickly if a deoxidizing agent (eg, trimethylamine, triethylamine, pyridine, sodium carbonate, potassium carbonate, etc.) is used. The carboxylic acid amide derivative obtained by the present invention can be heated in a solvent such as pyridine, water, or acetic acid in the presence of 2 to 3 times the molar amount of an oxidizing agent (e.g., potassium permanganate) to increase the yield. Anthranilic acid derivatives can be easily obtained. EXAMPLES The present invention will be explained in more detail with reference to Examples below. Example 1 A mixture of 2.1 g of 3,4,5-trimethoxybenzoic acid, 15 ml of dry benzene, and 2 ml of thionyl chloride was
After refluxing for an hour, the solvent was distilled off under reduced pressure. The residue was dissolved in 10 ml of dry tetrahydrofuran, added to a mixed solution of 1.4 g of 6-chloro-o-toluidine, 15 ml of dry tetrahydrofuran, and 1.5 ml of triethylamine, and stirred at room temperature for 2 hours. Next, the solvent was distilled off under reduced pressure, water was poured into the residue to obtain the product, and after drying, recrystallization from ethanol resulted in colorless prismatic crystals of 3,4,5-trimethoxybenzoyl-6-chloro-o. - Obtained 3.1g of toluidide. The melting point, infrared absorption spectrum, mass spectrum, and elemental analysis values of this substance were as follows. Melting point 165-167℃ Infrared absorption spectrum υc=o(KBr) 1630cm
-1 Mass spectrum M + 335 Elemental analysis value C 17 H 18 CNO 4 Theoretical value C: 60.81 H: 5.40 N: 4.17 Actual value C: 60.74 H: 5.47 N: 4.23 Example 2 3,4,5-trimethoxy A mixture of 2.1 g of benzoic acid, 15 ml of dry benzene, and 2 ml of thionyl chloride was
After refluxing for an hour, the solvent was distilled off under reduced pressure. The residue was dissolved in 10 ml of dry tetrahydrofuran, added to a mixed solution of 1.3 g of 4-fluoro-o-toluidine, 15 ml of dry tetrahydrofuran, and 1.5 ml of toluethylamine, and refluxed for 30 minutes. Next, water was poured into the solution to collect the precipitated crystals, and after drying, recrystallization from ethanol yielded 2.6 g of 3,4,5-trimethoxybenzoyl-4-fluoro-o-toluidide in the form of colorless needle-like crystals. Ta. The melting point, infrared absorption spectrum, mass spectrum, and elemental analysis values of this substance were as follows. Melting point 173-175℃ Infrared absorption spectrum νc=o(KBr) 1630cm
-1 Mass spectrum M + 319 Elemental analysis value C 17 H 18 FNO 4 Theoretical value C: 63.94 H: 5.68 N: 4.39 Actual value C: 63.83 H: 5.61 N: 4.46 Reference example 3,4,5-trimethoxy 7.0 g of benzoyl-5-chloro-o-toluidide was added to a mixed solution of pyridine and water (1:1), and 9.9 g of potassium permanganate was added in portions under reflux.
The mixture was further stirred under reflux for 15 hours. Next, the reaction mixture was filtered and the liquid was distilled off under reduced pressure. Add water to the residue, filter out insoluble matter, make the solution acidic with dilute hydrochloric acid under ice cooling, collect the precipitated crystals, dry and recrystallize from acetone to obtain colorless needle-shaped N-(3,4, 5.8 g of 5-trimethoxybenzoyl)-5-chloroanthranilic acid was obtained. The melting point and elemental analysis values of this substance were as follows. Melting point 273-275℃ Elemental analysis value C 17 H 16 CNO 6 Theoretical value C: 55.82 H: 4.41 N: 3.83 Actual measurement value C: 55.87 H: 4.36 N: 3.92 Examples 3-7 Examples 1-2 The following compound was synthesized according to the method. 【table】

Claims (1)

【特許請求の範囲】 1 一般式() (式中、Xはハロゲン原子を、mは1〜3の整数
を、nは0〜1の整数を意味する)で表わされる
カルボン酸アミド誘導体。
[Claims] 1 General formula () A carboxylic acid amide derivative represented by the formula (wherein, X represents a halogen atom, m represents an integer of 1 to 3, and n represents an integer of 0 to 1).
JP6285179A 1979-05-21 1979-05-21 Novel carboxylic acid amide derivative Granted JPS55154950A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6285179A JPS55154950A (en) 1979-05-21 1979-05-21 Novel carboxylic acid amide derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6285179A JPS55154950A (en) 1979-05-21 1979-05-21 Novel carboxylic acid amide derivative

Publications (2)

Publication Number Publication Date
JPS55154950A JPS55154950A (en) 1980-12-02
JPS6154016B2 true JPS6154016B2 (en) 1986-11-20

Family

ID=13212216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6285179A Granted JPS55154950A (en) 1979-05-21 1979-05-21 Novel carboxylic acid amide derivative

Country Status (1)

Country Link
JP (1) JPS55154950A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63119260U (en) * 1987-01-27 1988-08-02
JPH0484423U (en) * 1990-11-30 1992-07-22
JPH06314070A (en) * 1992-09-24 1994-11-08 Shiina:Kk Bollard and guide using it

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037751A2 (en) * 2002-08-29 2004-05-06 Temple University - Of The Commonwealth System Of Higher Education Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63119260U (en) * 1987-01-27 1988-08-02
JPH0484423U (en) * 1990-11-30 1992-07-22
JPH06314070A (en) * 1992-09-24 1994-11-08 Shiina:Kk Bollard and guide using it

Also Published As

Publication number Publication date
JPS55154950A (en) 1980-12-02

Similar Documents

Publication Publication Date Title
JPH0148911B2 (en)
JPS6154016B2 (en)
JPS5848545B2 (en) Shinki Hōkōzoku Carbon Sanamide Yudōtai no Seizō Hōhō
KR0146352B1 (en) Processes for the preparation of morniflumate and analogous compounds
US3238201A (en) Isatoic anhydride derivatives
US3168527A (en) 1-aryl-5-(p-fluorophenyl)-pyrrole-2-propionic acid compounds
EP0000152B1 (en) Oxaminic acids and esters, process for their preparation and pharmaceutical compositions containing them
JP2005504019A (en) Method for preparing isocoumarin
JPS6327337B2 (en)
JPS6312466B2 (en)
JPS6226260A (en) 7,7,8,8-tetracyanoquinodimethan-2,5-ylene-(3-propionic acid) and production thereof
JPS6148513B2 (en)
JPS6039064B2 (en) Novel phenyl acetate derivative
JPS6051465B2 (en) 3-Methyl-3-[4-(1-oxo-2-isoindolinyl)phenyl]pyruvic acid esters
JPH0378384B2 (en)
JPS584698B2 (en) Method for producing 2-(3-benzoylphenyl)propionic acid
JPH0427977B2 (en)
JPH0780812B2 (en) Azulene derivative thromboxane synthetase inhibitor and process for producing the same
JPS6148514B2 (en)
JPS5951939B2 (en) Method for producing isoindolinone derivatives
JPH0678291B2 (en) Process for producing cyano-substituted enol ether
JPH0128013B2 (en)
JPS634546B2 (en)
NO139170B (en) PROCEDURES FOR THE PREPARATION OF 4-ACETAMIDOPHENYL-2-ACETOXYBENZOATE
JPH027583B2 (en)